The CEO of BioNTech says the coronavirus vaccine it developed with Pfizer may need to be adapted to be more effective against the Omicron variant, cases of which have been confirmed in at least five U.S. states. Pulmonary specialist Dr. Len…
The CEO of BioNTech says the coronavirus vaccine it developed with Pfizer may need to be adapted to be more effective against the Omicron variant, cases of which have been confirmed in at least five U.S. states. Pulmonary specialist Dr. Len…